Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering
Actuate Therapeutics priced an $11.0 million underwritten public offering of 30,985,900 shares plus warrants to purchase 15,492,950 shares, at $0.71 per two-share-plus-one-warrant unit. The warrants carry a $0.45 exercise price, are immediately exercisable, and expire in five years; if fully exercised they could add roughly $7.0 million in gross proceeds. The underwriter also holds a 45-day option over up to 4,647,885 additional shares and warrants. Proceeds are earmarked for working capital and general corporate purposes, with closing expected October 28, 2026.
Key figures
- Deal Value Usd
- 11000000
- Offering Price
- 0.71
- Shares Offered
- 30985900
- Warrants offered
- 15492950
- Warrant exercise price
- 0.45
- Underwriter option shares
- 4647885
- Potential warrant proceeds
- $7.0 million
- Underwriter option warrants
- 2323942
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.